Page last updated: 2024-10-17

bupropion and Cholestasis, Intrahepatic

bupropion has been researched along with Cholestasis, Intrahepatic in 1 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Cholestasis, Intrahepatic: Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alvaro, D1
Onetti-Muda, A1
Moscatelli, R1
Atili, AF1

Other Studies

1 other study available for bupropion and Cholestasis, Intrahepatic

ArticleYear
Acute cholestatic hepatitis induced by bupropion prescribed as pharmacological support to stop smoking. A case report.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2001, Volume: 33, Issue:8

    Topics: Acute Disease; Antidepressive Agents, Second-Generation; Bupropion; Chemical and Drug Induced Liver

2001